Sandoz TV Episode 18: Trailer
Find out what to expect from the newest episode of Sandoz TV.
|Global News||Sandoz Around the World||Sandoz in the Media|
Sandoz’s Carol Lynch, Global Head Biopharmaceuticals is recognized in a Top 100 list, as the eighth most influential individual in medicine making.
Holzkirchen, April 29, 2016
Sandoz’s Carol Lynch, Global Head Biopharmaceuticals, has been named as one of the most influential people involved in bringing medicines to patients
Novartis Q1 Results 2016
Basel, April 21, 2016
Novartis delivered solid Q1 despite Gleevec loss of exclusivity; investing behind new launches for long-term growth.
Sandoz receives EC approval for subcutaneous route of administration in biosimilar Binocrit’s® nephrology indication
Holzkirchen, April 08, 2016
EC approval expands Sandoz biosimilar offering to the healthcare community
Novartis publishes updated 2015 segment financials reflecting new division structure
Basel, March 31, 2016
Novartis announced today that it has published updated 2015 quarterly and full year segment financials reflecting the new division structure, as announced in the January 27, 2016 earnings release, as if the transfers had taken place from January 1, 2015.
New research highlights need for a competitive functioning biologics market to achieve full potential of biosimilars
Holzkirchen, March 29, 2016
New research published today in a report from the IMS Institute for Healthcare Informatics